Groups Voice Support for Drug Shortages Bill; FDA Reports on Root Causes

The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices voiced strong support for the Mitigating Emergency Drug Shortages Act (S.2723), which includes provisions recommended by a recent drug shortages summit convened by the organizations. Introduced by Sens. Susan Collins, R-Maine, and Tina Smith, D-Minn., the legislation would require manufacturers to disclose the root causes and expected duration of shortages, and develop contingency plans to ensure an ongoing supply. It also would extend reporting requirements to include contract manufacturers and active pharmaceutical ingredients; develop recommendations to incentivize manufacturers to enter the market for drugs in shortage; and examine the national security risk of shortages.

Related Resources

Letter/Comment
May 26, 2020 The Honorable Chip Roy U.S. House of Representatives 1319 Longworth House Office Building Washington, DC 20515 Dear Representative Roy: On…
Letter/Comment
Public
The AHA urges leaders of the House and Senate Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies to support…
Letter/Comment
Public
Dear Leader McConnell, Speaker Pelosi, Leader Schumer and Leader McCarthy:  As organizations representing hospitals, health systems and other health care…
Letter/Comment
Public
The American Hospital Association is pleased to support the Rural Community Hospital Demonstration Extension Act of 2020.  The Medicare Rural…
Letter/Comment
April 19, 2020 The Honorable Kevin McCarthy House Republican Leader H-204 Capitol Building Washington, DC 20515 Dear Leader McCarthy: On behalf of our…
Advisory
Public
The House of Representatives yesterday released the Families First Coronavirus Response Act (H.R. 6201) in response to the novel coronavirus (COVID-19)…